Ctso investor relations
WebTitle. 03/16/23. CATO REPORTS 4Q AND FULL YEAR EARNINGS. Print Page. 02/24/23. THE CATO CORPORATION ANNOUNCES REGULAR QUARTERLY DIVIDEND AND INCREASED SHARE REPURCHASE AUTHORIZATION. WebThe corporate website includes broad information about Cerus, resources for investors, and career opportunities. INTERCEPT-USA.com ... Investor Relations Contact. Phone: 925 …
Ctso investor relations
Did you know?
WebMay 19, 2024 · May 19, 2024 - 7:00 am. MONMOUTH JUNCTION, N.J., May 19, 2024-- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces management will present at two upcoming in–person investor conferences. Web01/31 07:15. Cytosorbents Corporation's (NASDAQ:CTSO) market cap touched US$103m last week, benefiting both individual investors who own 52% as well as institutions. Yahoo. 01/29 09:58. Cytosorbents Receives Health Canada's Approval for STAR-T Trial.
WebCTSO: Career and Technical Student Organizations: CTSO: Chief Technology and Services Officer: CTSO: Cellular Telephone Switching Office: CTSO: Certified Thermal Spray … WebOct 27, 2024 · Oct. 27, 2024, 07:00 AM. PRINCETON, N.J., Oct. 27, 2024 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit ...
WebOpen Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in XLS file. SC 13G/A. Amendment to a previously filed SC 13G. Jun 28, 2024. Open Amendment to a previously filed SC 13G in HTML. WebCytoSorbents aims to be in the elite company of fast growing medical device companies, with rapid growth, industry leading product gross margins in excess of 80%, and GAAP … Cytosorbents investor relations upcoming and archived events and presentations. …
WebApr 12, 2024 · 1 Wall Street research analysts have issued 1-year target prices for Cytosorbents' shares. Their CTSO share price forecasts range from $5.50 to $6.00. On average, they anticipate the company's share price to reach $5.75 in the next twelve months. This suggests a possible upside of 80.3% from the stock's current price.
WebOct 27, 2024 · Oct. 27, 2024, 07:00 AM. PRINCETON, N.J., Oct. 27, 2024 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life … ions driving directionsWeb6、有一定的EMC、可靠性设计概念，了解DO-160、各类ARINC、RTCA-DO、CTSO者优先7、有较强的文档写作能力，能够比较系统完整地定义机载通讯产品。8、具备跨语言、跨文化、跨行业的沟通协调能力及人际关系处理能力，有团队工作意识。 ... Investor Relations. ontheffing milieuzone rotterdamWebDec 5, 2024 · CTSO Increment 1 fulfills a U.S. Army directive to replace obsolete munitions with next-generation technology that enables soldiers to effectively conduct terrain-shaping operations against peer threats. ... Eric Salander, Vice President, Investor Relations (401) 457-2288. Cameron Vollmuth, Manager, Investor Relations (401) 457-2288. Email ... ontheffing leerplichtWebApr 12, 2024 · During the previous two years, 74 institutional investors and hedge funds held shares of Cytosorbents. The most heavily invested institutionals were Granahan Investment Management Inc. MA ($9.38M), BlackRock Inc. ($8.30M), Vanguard Group Inc. ($7M), Skylands Capital LLC ($3.94M), Avenir Corp ($3.79M), Redmile Group LLC … ions domain checkWebJun 1, 2024 · CytoSorbents Appoints Terri Anne Powers, IRC as Vice President of Investor Relations and Corporate Communications Terri Anne Powers, IRC, experienced financial and communications professional, to stre... ontheffing inburgeringsplicht naturalisatieWebFeb 15, 2024 · Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly … ions domain nameWebFeb 9, 2024 · Investor Relations. NYSE: CTS 45.28. -0.62 ( -1.35% ) Pricing delayed by 20 minutes. ontheffing leerplicht autisme